You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
28 April 2026 - US healthcare company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Monday that the US Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY (nipoc...
28 April 2026 - US pharmaceutical company Xcovery Holdings Inc announced on Monday an agreement with EVERSANA, a provider of commercialisation services to the global life sciences industry, to support and expand the US commercial launch of Ensacove (...
28 April 2026 - US pharmaceutical company Jazz Pharmaceuticals plc (Nasdaq:JAZZ) announced on Monday that the US Food and Drug Administration (FDA) has accepted for filing with Priority Review the supplemental Biologics License Application (sBLA) for...
27 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that it has received Breakthrough Therapy Designation from the US Food and Drug Administration, as well as Priority Medicines (PRIME) designation from the Eu...
27 April 2026 - Pharmaceutical company Shield Therapeutics plc (LSE: STX) announced on Monday that its partner MEDLEAP Pharma, a subsidiary of Vital KSK Holdings Inc, has enrolled the first patient in a Phase II clinical trial of ACCRUFeR (ferric mal...
27 April 2026 - Veradermics Inc (NYSE:MANE), a late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, on Monday announced positive topline results from its Phase 2/3 Study '302' evaluating ...